Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Free Cash Flow (2019 - 2025)

Volitionrx's Free Cash Flow history spans 9 years, with the latest figure at -$5.5 million for Q4 2025.

  • For Q4 2025, Free Cash Flow changed 0.03% year-over-year to -$5.5 million; the TTM value through Dec 2025 reached -$19.8 million, up 24.45%, while the annual FY2025 figure was -$19.8 million, 24.45% up from the prior year.
  • Free Cash Flow reached -$5.5 million in Q4 2025 per VNRX's latest filing, down from -$3.6 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $7.2 million in Q4 2023 to a low of -$9.2 million in Q3 2023.
  • Average Free Cash Flow over 5 years is -$5.1 million, with a median of -$6.0 million recorded in 2021.
  • The largest YoY upside for Free Cash Flow was 213.17% in 2023 against a maximum downside of 356.63% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at -$4.5 million in 2021, then tumbled by 40.65% to -$6.4 million in 2022, then surged by 213.17% to $7.2 million in 2023, then tumbled by 176.21% to -$5.5 million in 2024, then grew by 0.03% to -$5.5 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Free Cash Flow are -$5.5 million (Q4 2025), -$3.6 million (Q3 2025), and -$6.3 million (Q2 2025).